申请人:Pierre Fabre S.A.
公开号:US04380667A1
公开(公告)日:1983-04-19
The present invention relates to 2'-(ortho-chlorobenzoyl)-4'-chloroglycylanilides, compositions thereof, and their use as medicaments, e.g., as anxiolytic agents. The compounds of the invention have the general formula I ##STR1## in which R represents hydrogen or alkyl, R.sub.1 and R.sub.2 may be identical or different and are selected from hydrogen, alkyl, hydroxyalkyl, alkenyl, and alkynyl, possibly substituted by alkyl, and cycloalkyl having three to six members, possibly substituted by alkyl, with the proviso that, when one of R.sub.1 and R.sub.2 represents hydrogen, the other is not lower alkyl or hydroxyalkyl; and with the further proviso that R.sub.1 and R.sub.2 may not simultaneously represent either hydrogen or lower alkyl. R.sub.1 and R.sub.2 may furthermore form, with the nitrogen atom to which they are connected, a nitrogen heterocycle possibly containing a second heteroatom selected from oxygen and nitrogen.
本发明涉及2'-(邻氯苯甲酰)-4'-氯甘氨基苯酰胺,其组成物以及作为药物的使用,例如作为抗焦虑剂。本发明的化合物具有通式I
其中,R代表氢或烷基,R1和R2可以相同也可以不同,选自氢、烷基、羟基烷基、烯基和炔基,可能被烷基取代,以及具有三到六个成员的环烷基,可能被烷基取代,但是当R1和R2中的一个代表氢时,另一个不是低级烷基或羟基烷基;并且进一步规定R1和R2不能同时代表氢或低级烷基。R1和R2还可以与它们连接的氮原子形成含有第二个杂原子(选自氧和氮)的氮杂环。